Development of CDD-0102 as a selective M1 agonist for the treatment of Alzheimer's disease

2002 ◽  
Vol 57 (4) ◽  
pp. 200-213 ◽  
Author(s):  
William S. Messer ◽  
Kenneth A. Bachmann ◽  
Colleen Dockery ◽  
Afif A. El-Assadi ◽  
Ezdihar Hassoun ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
M1 Agonist

scholarly journals P2-448: Preclinical evaluation of CDD-0102, a selective M1 agonist with potential utility in Alzheimer's disease

2008 ◽  
Vol 4 ◽  
pp. T505-T505
Author(s):  
William S. Messer ◽  
Karen Steinmetz ◽  
Toufan Parman ◽  
Paul Catz ◽  
Carol Green ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Potential Utility ◽  
Preclinical Evaluation ◽  
M1 Agonist

Cognitive control constrains memory attributions

2019 ◽  
Vol 42 ◽  
Author(s):  
Colleen M. Kelley ◽  
Larry L. Jacoby
Keyword(s):  
Alzheimer’S Disease ◽  
Older Adults ◽  
Alzheimer's Disease ◽  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Cognitive Control

Abstract Cognitive control constrains retrieval processing and so restricts what comes to mind as input to the attribution system. We review evidence that older adults, patients with Alzheimer's disease, and people with traumatic brain injury exert less cognitive control during retrieval, and so are susceptible to memory misattributions in the form of dramatic levels of false remembering.

Sign in / Sign up

Export Citation Format

Share Document